Clinical Trial Update: A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating how different insulin needle features affect the pharmacokinetic profile of insulin aspart. The study was completed and sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• NovoLog (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes | Phase 1 | Status: COMPLETED